<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00215085</url>
  </required_header>
  <id_info>
    <org_study_id>05-091</org_study_id>
    <nct_id>NCT00215085</nct_id>
  </id_info>
  <brief_title>Cardiac Tumors in Children</brief_title>
  <official_title>Cardiac Tumors in Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Healthcare of Atlanta</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Children's Healthcare of Atlanta</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to define the natural history of untreated cardiac tumors, study&#xD;
      the pathology of primary cardiac tumors, review the surgical treatment and results of primary&#xD;
      cardiac tumors and to determine the prognosis for these tumors.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary cardiac tumors in children are extremely rare. Benign tumors are typically myxomas,&#xD;
      lipomas, and rhabdomyomas, while malignant tumors are typically angiosarcomas and&#xD;
      rhabdomyosarcomas. Due to the rarity of these tumors, it is difficult to gather meaningful&#xD;
      information regarding their natural history, pathology and treatment.&#xD;
&#xD;
      The primary aims are to define the natural history of untreated cardiac tumors, study the&#xD;
      pathology of primary cardiac tumors, review the surgical treatment and results of primary&#xD;
      cardiac tumors and to determine the prognosis for these tumors. The secondary aims are to&#xD;
      discover patterns and consistencies among primary cardiac tumors and to define the best&#xD;
      treatment options for these patients. The study will be conducted through a retrospective&#xD;
      chart review of about 70 patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    insufficient data&#xD;
  </why_stopped>
  <start_date>May 2005</start_date>
  <completion_date type="Actual">November 2006</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Congenital Heart Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients in the congenital surgery database&#xD;
&#xD;
          -  Children who have been treated for a primary cardiac tumor&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients in the congenital surgery database&#xD;
&#xD;
          -  Children who have been treated for a primary cardiac tumor&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brian Kogon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Emory University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's Healthcare of Atlanta</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2007</verification_date>
  <study_first_submitted>September 20, 2005</study_first_submitted>
  <study_first_submitted_qc>September 20, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2005</study_first_posted>
  <last_update_submitted>March 14, 2012</last_update_submitted>
  <last_update_submitted_qc>March 14, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 16, 2012</last_update_posted>
  <keyword>pediatric health</keyword>
  <keyword>cardiac</keyword>
  <keyword>cardiac tumor</keyword>
  <keyword>children</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Neoplasms</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Defects, Congenital</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

